Related Experiment Video
Updated: Jul 11, 2025

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
Beyond Blood Sugar: Investigating the Cardiovascular Effects of Antidiabetic Drugs
Binish A Ahmad1, Isha M Sanghani2, Rithika Sayabugari3
1Department of Internal Medicine, King Edward Medical University, Lahore, PAK.
Abstract:
Cardiovascular disease is a major comorbidity associated with diabetes mellitus. Various antidiabetic drugs are currently used to treat type 2 diabetes mellitus and have varying effects on the cardiovascular system. Some drugs, such as glucagon-like peptide 1 (GLP-1) agonists and sodium-glucose cotransporter 2 (SGLT-2) inhibitors, are cardioprotective, whereas others, such as insulin, have deleterious effects on the cardiovascular system. This narrative review assessed the impact of antidiabetic drugs on cardiovascular health in the management of diabetes mellitus. It critically examines various classes of these medications, including conventional options such as metformin and newer agents such as incretin-based therapies and SGLT-2.
Related Concept Videos
Oral Hypoglycemic Agents: Biguanides and Glitazones
Cardiovascular Drugs: Classification based on Therapeutic Indications
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Antihypertensive Drugs: Action of β1 Blockers
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antihypertensive Drugs: Action of Diuretics

